AI has become increasingly important in the field of oncology and hematology. It is being used for diagnosis, staging, and treatment decision-making. However, there are concerns about potential misuse, privacy breaches, and a loss of personalization in patient care. Healio has provided updates on AI in clinical settings, including a study that showed an AI model accurately predicted the risk of prostate cancer metastasis better than traditional guidelines. This suggests that AI could help reduce unnecessary treatment in the future. The use of AI in oncology and hematology is promising but also raises ethical and practical challenges.
Source link
AI in cancer care: Promise, perils and the importance of ‘responsible use’
